New prostate cancer scan identified 91% of cases in study, potentially avoiding biopsies - WUSA9
New prostate cancer scan identified 91% of cases in study, potentially avoiding biopsies WUSA9
Prostate Cancer News
James Pickens Jr.’s Wife Eased Fears After Prostate Cancer (Exclusive) - People.com
James Pickens Jr.’s Wife Eased Fears After Prostate Cancer (Exclusive) People.com
Talazoparib plus enzalutamide in high-volume metastatic hormone-naive prostate cancer: a randomized phase 2 trial - Nature
Talazoparib plus enzalutamide in high-volume metastatic hormone-naive prostate cancer: a randomized phase 2 trial Nature
Lead singer of Darik and the Funbags dies of prostate cancer at 54 - NBC Connecticut
Lead singer of Darik and the Funbags dies of prostate cancer at 54 NBC Connecticut
Labcorp to buy BioReference assets for up to $872M - MedTech Dive
Labcorp to buy BioReference assets for up to $872M MedTech Dive
AI matches radiologists at prostate cancer detection via MRI - Radiology Business
AI matches radiologists at prostate cancer detection via MRI Radiology Business
Falcons game to host free prostate cancer screening - FOX 5 Atlanta
Falcons game to host free prostate cancer screening FOX 5 Atlanta
NCS AUA 2026: Intraprostatic PSMA PET Avidity is Associated with Cribriform Carcinoma: A Multicenter Retrospective Cohort Study - UroToday
NCS AUA 2026: Intraprostatic PSMA PET Avidity is Associated with Cribriform Carcinoma: A Multicenter Retrospective Cohort Study UroToday
McGovern runs for prostate cancer - Vertikal
McGovern runs for prostate cancer Vertikal
A Hidden Molecular Switch Could Change How We Treat Aggressive Prostate Cancer - SciTechDaily
A Hidden Molecular Switch Could Change How We Treat Aggressive Prostate Cancer SciTechDaily
Collaboration Seeks to Develop Prostate Cancer Companion Diagnostic for Local Lab Testing - Clinical Lab Products
Collaboration Seeks to Develop Prostate Cancer Companion Diagnostic for Local Lab Testing Clinical Lab Products
Targeted radioactive therapy may help delay spread of recurrent prostate cancer, UCLA study suggests - UCLA Health
Targeted radioactive therapy may help delay spread of recurrent prostate cancer, UCLA study suggests UCLA Health
Enrique Grande: Rethinking Research Priorities Across Prostate, Kidney and Bladder Cancer - Oncodaily
Enrique Grande: Rethinking Research Priorities Across Prostate, Kidney and Bladder Cancer Oncodaily
Labcorp to buy medical diagnostics company, proprietary prostate cancer test in $872M deal - HealthExec
Labcorp to buy medical diagnostics company, proprietary prostate cancer test in $872M deal HealthExec
Radioligand Plus Radiation Delays Prostate Cancer Progression to 17.6 Months - Cure Today
Radioligand Plus Radiation Delays Prostate Cancer Progression to 17.6 Months Cure Today
Key driver of aggressive prostate cancer identified, suggesting new way to reverse drug resistance - Fred Hutchinson Cancer Center
Key driver of aggressive prostate cancer identified, suggesting new way to reverse drug resistance Fred Hutchinson Cancer Center
Dr Morgans on Cognitive Effects of Darolutamide vs Enzalutamide in Prostate Cancer - Targeted Oncology
Dr Morgans on Cognitive Effects of Darolutamide vs Enzalutamide in Prostate Cancer Targeted Oncology
In Good Health: The Evolution Of Prostate Cancer Treatment : 1A - NPR
In Good Health: The Evolution Of Prostate Cancer Treatment : 1A NPR
Managing Side Effects of Treatment for Advanced Prostate Cancer - MedPage Today
Managing Side Effects of Treatment for Advanced Prostate Cancer MedPage Today
Lu-177 PNT2002 before SBRT extends disease control in prostate cancer - AuntMinnie
Lu-177 PNT2002 before SBRT extends disease control in prostate cancer AuntMinnie
Actinium Pharmaceuticals Announces Oral Presentation at EANM 2026 Highlighting First-in-Human Phase 1 Study of ATNM-400, a Non-PSMA Targeting Radiotherapy, in Prostate Cancer - PR Newswire
Actinium Pharmaceuticals Announces Oral Presentation at EANM 2026 Highlighting First-in-Human Phase 1 Study of ATNM-400, a Non-PSMA Targeting Radiotherapy, in Prostate Cancer PR Newswire
CT remembers Darik and the Funbags frontman and musician Darik Pearson - New Haven Register
CT remembers Darik and the Funbags frontman and musician Darik Pearson New Haven Register
New prostate cancer scan identified 91% of cases in study, potentially avoiding biopsies - 9News
New prostate cancer scan identified 91% of cases in study, potentially avoiding biopsies 9News
Raise Awareness for Prostate Cancer at the ZERO Prostate Cancer Run/Walk in Raleigh - CBS 17
Raise Awareness for Prostate Cancer at the ZERO Prostate Cancer Run/Walk in Raleigh CBS 17
Why Healthy Lifestyles Can Still Lead to Metastatic Prostate Cancer - Cure Today
Why Healthy Lifestyles Can Still Lead to Metastatic Prostate Cancer Cure Today
Abhishek A. Solanki: F-SHARP Points to Risk-Adapted Salvage Re-Irradiation in Prostate Cancer - Oncodaily
Abhishek A. Solanki: F-SHARP Points to Risk-Adapted Salvage Re-Irradiation in Prostate Cancer Oncodaily
tRNA dosage regulates lineage dependency and resistance in prostate cancer - Nature
tRNA dosage regulates lineage dependency and resistance in prostate cancer Nature
Lantheus' shelved radioligand PNT2002 shows promise in earlier prostate cancer in UCLA trial - AllSci
Lantheus' shelved radioligand PNT2002 shows promise in earlier prostate cancer in UCLA trial AllSci
Texas Panhandle men invited to free prostate cancer screening in Amarillo Thursday - KFDA | NewsChannel 10
Texas Panhandle men invited to free prostate cancer screening in Amarillo Thursday KFDA | NewsChannel 10
Neuroendocrine Prostate Cancer Market to Witness Growth at a 25% CAGR by 2036 Due to the Emergence of Emerging agents, including DLL3-targeted Therapies, ADCs, BsAbs, CAR-Ts, Aurora Kinase Inhibitors, and EZH2 Inhibitors | DelveInsight - PR Newswire
Neuroendocrine Prostate Cancer Market to Witness Growth at a 25% CAGR by 2036 Due to the Emergence of Emerging agents, including DLL3-targeted Therapies, ADCs, BsAbs, CAR-Ts, Aurora Kinase Inhibitors, and EZH2 Inhibitors | DelveInsight PR Newswire
Dillon Cockrell: ESMO26 is Approaching With Several Key GU Studies Being Presented Next Week - Oncodaily
Dillon Cockrell: ESMO26 is Approaching With Several Key GU Studies Being Presented Next Week Oncodaily
What Data Should Radiation Oncologists Know From ASTRO 2026? - CancerNetwork
What Data Should Radiation Oncologists Know From ASTRO 2026? CancerNetwork
MRI Tumor Stage Emerges as Powerful Predictor of Nodal Spread on PSMA PET in High-Risk Prostate Cancer - Bioengineer.org
MRI Tumor Stage Emerges as Powerful Predictor of Nodal Spread on PSMA PET in High-Risk Prostate Cancer Bioengineer.org
Integrated signatures define mutational processes in prostate cancer - Nature
Integrated signatures define mutational processes in prostate cancer Nature
Prostate Cancer - Focused Ultrasound Foundation
Prostate Cancer Focused Ultrasound Foundation
Prostate Cancer Statistics 2026 - Cancer Therapy Advisor
Prostate Cancer Statistics 2026 Cancer Therapy Advisor
Beyond the PSA Test: New Approaches to Prostate Cancer Care at UNC - UNC Health
Beyond the PSA Test: New Approaches to Prostate Cancer Care at UNC UNC Health
Healthier fats linked to longer survival after prostate cancer diagnosis - Harvard T.H. Chan School of Public Health
Healthier fats linked to longer survival after prostate cancer diagnosis Harvard T.H. Chan School of Public Health
Cancer survivor cycles around the world to raise awareness for cancer research - KSL News
Cancer survivor cycles around the world to raise awareness for cancer research KSL News
New drug combination may help treat advanced prostate cancer - Michigan Medicine
New drug combination may help treat advanced prostate cancer Michigan Medicine